Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Breast cancer
2019 Standout
HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study
2003
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
2003
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Development of antibodies to the nonstructural Protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtful
1998
The transfusion-associated transmission of parvovirus B19
1999
Testicular Germ-Cell Cancer
1997 Standout
Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
2000
Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle
2000
Clinical management of BRCA1 and BRCA2 mutation carriers
2006
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 Standout
Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral Therapy
2001
Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin‐6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections?
2002
Heating the patient: a promising approach?
2002 Standout
Expression and Characterization of a Murine Enzyme Able to Cleave β-Carotene
2001
Fifth (human parvovirus) and sixth (herpesvirus 6) diseases
2001
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
The cellular and molecular basis of hyperthermia
2002 Standout
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Genetic counselors: translating genomic science into clinical practice
2003
Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy
2003
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Review of sampling hard-to-reach and hidden populations for HIV surveillance
2005 Standout
IgG Response to the Immunoreactive Region of Parvovirus B19 Nonstructural Protein by Immunoblot Assay with a Recombinant Antigen
1998
PTEN hamartoma tumor syndromes
2008 Standout
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
2004
Recent Advances in Breast Cancer Genetics
2007
Consensus Statement on Management of Intersex Disorders
2006 Standout
Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood
2003
Sequence variability among different parvovirus B19 isolates
1996
Antibodies to parvovirus B19 non‐structural protein are associated with chronic but not acute arthritis following B19 infection
2000
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Parvovirus B19
2004 Standout
Prevalence of Antibodies to Human Parvovirus B19 Nonstructural Protein in Persons with Various Clinical Outcomes following B19 Infection
1999
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
1997
Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection
2001
Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia
1999
Human Parvovirus B19
2002 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Characterization of cis -Acting and NS1 Protein-Responsive Elements in the p6 Promoter of Parvovirus B19
1998
Diversifying Carotenoid Biosynthetic Pathways by Directed Evolution
2005 StandoutNobel
COMPLIANCE OF CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR PATIENTS WITH SURVEILLANCE
1998
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
1999
Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein
1996
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial
2002
Hyperthermia for the treatment of patients with malignant germ cell tumors
1998
RHEUMATIC MANIFESTATIONS OF PARVOVIRUS B19 INFECTION
1998
A New Definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force Report
2006 Standout
Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis.
2004 Standout
Carcinoma in situ in the Testis
2000
Lymphoproliferative responses after infection with human parvovirus B19
1996
Works of J. Pont being referenced
Testis‐preserving surgery in bilateral testicular germ cell tumours
1997
Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
1996
Incidence of Metachronous Testicular Cancer in Patients With Extragonadal Germ Cell Tumors
2001
Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.
1990
Antibodies to the Nonstructural Protein of Parvovirus B19 in Persistently Infected Patients: Implications for Pathogenesis
1995
Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV- I, HBV, HCV) in Austrian intravenous drug users
1991
Treatment Decision for Stage I Non‐seminomatous Germ Cell Tumours Based on the Risk Factor “Vascular Invasion”
1992
Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
1994